NCT02288234 - Telavancin Observational Use Registry (TOUR) | Biotech Hunter

Enrollment

1,063

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

October 31, 2017

Conditions

Hospital Acquired Bacterial PneumoniaComplicated Skin and Skin Structure InfectionsVentilator Associated Bacterial PneumoniaGram Positive Infection

Interventions

DRUG

Vibativ

This is an observational study for patients who were already prescribed Vibativ.

Trial Locations (1)

Newland Medical Associates, Southfield